Centrum Onkologii KOMED

Konin

0 studies enrolling now · 1 studies all time

What they study most

HER2 Exon 20 Mutation, Non-squamous NSCLC

Studies at this site

• Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based Chemotherapy — Completed